CTDH

Cyclo Therapeutics (QB) Stock Price

0.075
0.01 (15.38%)
0.075
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Cyclo Therapeutics Inc (QB) CTDH OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 15.38% 0.075 13:28:16
Open Price Low Price High Price Close Price Previous Close
0.07005 0.0651 0.075 0.065
Bid Price Ask Price Spread News
0.065 0.075 0.01 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
45 270,900 $ 0.071949 $ 19,491 349,984 0.034 - 0.3499
Last Trade Time Type Quantity Stock Price Currency
12:57:00 2,000 $ 0.075 USD

Cyclo Therapeutics (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 12.75M 169.98M 60.13M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
42.33k $ - 0.00% - -

more financials information »

Cyclo Therapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTDH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.04990.08750.04990.0651497670,2130.025150.3%
1 Month0.1590.1590.0340.0650806505,263-0.084-52.83%
3 Months0.170.190.0340.1099827356,106-0.095-55.88%
6 Months0.16750.2350.0340.1291485258,610-0.0925-55.22%
1 Year0.260.34990.0340.1529033218,786-0.185-71.15%
3 Years0.331761.180.0340.1907674114,346-0.25676-77.39%
5 Years0.59991.180.0340.205612579,181-0.5249-87.5%

Cyclo Therapeutics (QB) Description

Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer's Disease. The company's Trappsol(R) Cyclo(TM), an orphan drug designated product in the United States and the EU, is used to treat Niemann-Pick Type C, a rare and fatal genetic disease. Additional indications for the active ingredient in Trappsol(R) Cyclo(TM) are in development. For additional information, visit the company's website: www.cyclotherapeutics.com


Your Recent History
USOTC
CTDH
Cyclo Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.